-
Product Insights
Innovations in Dermatology – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Dermatology - Global Pipeline Summary" provides comprehensive information about the Dermatology pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Dermatology report provides key information and data related to: Extensive coverage of the Dermatology under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Abrocitinib in Dermatological Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Abrocitinib in Dermatological Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Abrocitinib in Dermatological Disorders Drug Details: Abrocitinib (Cibinqo / Freorla) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tofacitinib Citrate in Dermatological Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tofacitinib Citrate in Dermatological Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tofacitinib Citrate in Dermatological Disorders Drug Details: tofacitinib citrate is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GDD-3898 in Dermatological Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GDD-3898 in Dermatological Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GDD-3898 in Dermatological Disorders Drug Details: GDD-3898 is under development for...
-
Product Insights
Likelihood of Approval Analysis for Dermatological Disorders
Overview How likely is it that the drugs in Dermatological Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dermatological Disorders Overview Dermatological disorders are diseases or conditions that affect the...
-
Product Insights
NewDermatological Disorders – Drugs In Development, 2024
Empower your strategies with our Dermatological Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Dermatological disorders are diseases or conditions that affect the skin, hair, or nails. They can have various causes, symptoms, and treatments. Some of the most common dermatological disorders are acne, eczema, psoriasis, rosacea, and warts. Dermatologists are doctors who specialize in diagnosing and treating these disorders. Dermatological disorders can affect the appearance, function, and quality of life of the patients. Some of...
-
Product Insights
NewMelanocyte Stimulating Hormone Receptor – Drugs In Development, 2024
The Melanocyte Stimulating Hormone Receptor pipeline drugs market research report outlays comprehensive information on the Melanocyte Stimulating Hormone Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology, Dermatology, Gastrointestinal, and Oncology which include indications of Diabetic Retinopathy, Uveitis, Vitiligo, Unspecified Dermatological Disorders, Inflammatory Bowel Disease, Peritonitis, Melanoma, and Metastatic Melanoma. It also reviews key players involved...
-
Product Insights
NewP2X Purinoceptor 3 – Drugs In Development, 2024
The P2X Purinoceptor 3 pipeline drugs market research report outlays comprehensive information on the P2X Purinoceptor 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Respiratory, Dermatology, and Women's Health which include indications of Pain, Visceral Pain, Chronic Cough, Cough, Dermatology, Pruritus, and Endometriosis. It also reviews key players involved in P2X Purinoceptor 3...
-
Product Insights
NewInterleukin 1 Receptor Like 2 – Drugs In Development, 2024
The Interleukin 1 Receptor Like 2 pipeline drugs market research report outlays comprehensive information on the Interleukin 1 Receptor Like 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Dermatology, Gastrointestinal, and Respiratory which include indications of Generalized Pustular Psoriasis (GPP), Psoriasis, Hidradenitis Suppurativa, Dermatology, Ulcerative Colitis, Inflammatory Bowel Disease, and Idiopathic Pulmonary Fibrosis. It also...
-
Product Insights
NewInterleukin 23 – Drugs In Development, 2024
The Interleukin 23 pipeline drugs market research report outlays comprehensive information on the Interleukin 23 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Gastrointestinal, Musculoskeletal Disorders, and Dermatology which include indications of Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis, Crohn's Disease (Regional Enteritis), Ulcerative Colitis, Psoriatic Arthritis, Axial Spondyloarthritis, Hidradenitis Suppurativa, and Dermatological Disorders. It also reviews key...